ZOLEDRONIC ACID FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH OSTEOGENESIS IMPERFECTA: DENSITOMETRIC IMPROVEMENT AND CONVENIENT DOSING SCHEDULE

被引:0
|
作者
Morales Tavera, L. M. [1 ]
Munhoz Serra, A. [1 ]
Menezes Filho, H. [1 ]
Carame Helito, A. [1 ]
Romero Bertola, D. [1 ]
Chong Ae, K. [1 ]
Della Mana, T. [1 ]
Rocha Franco, R. [1 ]
Steinmetz, L. [1 ]
Cominato, L. [1 ]
Damiani, D. [1 ]
机构
[1] Univ Sao Paulo, Sao Paulo, Brazil
来源
关键词
Zoledrinic Acid; Bone mineral density; Osteogenesis imperfecta;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PPF2
引用
收藏
页码:21 / 22
页数:2
相关论文
共 50 条
  • [31] Efficacy and safety of intravenous Zolidronic acid in the treatment of pediatric osteogenesis imperfecta: a systematic review
    Mahmoud, Ines
    Bouden, Selma
    Sahli, Mariem
    Rouached, Leila
    Ben Tekaya, Aicha
    Tekaya, Rawdha
    Saidane, Olfa
    Abdelmoula, Leila
    JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B, 2024, 33 (03): : 283 - 289
  • [32] Radiation exposure in adult and pediatric patients with osteogenesis imperfecta
    Perchik, Jordan D.
    Murphy, Ryan P.
    Kelly, Derek M.
    Sawyer, Jeffrey R.
    JOURNAL OF ORTHOPAEDICS, 2019, 16 (04) : 320 - 324
  • [33] Characterization of hearing loss in pediatric patients with osteogenesis imperfecta
    Cleveland, Chelsea
    Hayden, Jamil
    Baglam, Tekin
    Otteson, Todd
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2024, 183
  • [34] Anthropometric and Nutritional Parameters in Egyptian Children with Osteogenesis Imperfecta: Effect of Zoledronic Acid Therapy
    Hamza, Rasha
    Abdelaziz, Tarek
    Elakkad, Magdy
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 186 - 186
  • [35] Effect of cyclical pamidronate treatment in pediatric patients with severe and mild forms of osteogenesis imperfecta
    Marowska, J
    Jelonek, E
    Olszaniecka, M
    Kobylinska, M
    Matusik, H
    Lebiedowski, M
    Lorenc, RS
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S35 - S35
  • [36] ORAL RISEDRONATE TREATMENT IN VARIOUS FORMS OF PEDIATRIC OSTEOGENESIS IMPERFECTA
    Molakalapalli, S.
    Nguyen, A.
    Pitukcheewanont, P.
    Ryabets-Lienhard, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP542 - NP543
  • [37] Renal function in pediatric osteogenesis imperfecta patients receiving pamidronate
    Land, Christof
    Rauch, Frank
    Travers, Rose
    Glorieux, Francis H.
    HORMONE RESEARCH, 2006, 65 : 131 - 131
  • [38] Three years AlendronAtE therapy of pediatric patients with osteogenesis imperfecta
    Vyskocil, V
    BONE, 2004, 34 : S98 - S98
  • [39] Safety and efficacy of the use of zoledronic acid (AZ) in children with osteogenesis imperfecta - Preliminary data.
    Ribeiro, E
    Saraiva, G
    Maeda, S
    Castaldoni, A
    Lazaretti-Castro, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S176 - S176
  • [40] The Effect of Zoledronic Acid on Reducing Fracture Rates in Youth with Osteogenesis Imperfecta and Other Forms of Osteoporosis
    Stoffers, Ashley
    Weber, David
    Mayer, Michael
    Monk, Heather M.
    Rosano, Joseph
    Pizza, Jennifer
    Scully, Tryce
    Levine, Michael
    Mancilla, Edna
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 2): : 11 - 12